During this webinar Camille Hurley from the Royal College of Surgeons in Ireland presents on investigating the immune landscape of HER2+ breast cancer tumours to identify potential biomarkers of response to HER2-targeting therapies.
She describes her use of 3plex immunohistochemistry and AI algorithm training for quantitative, multiplex image analysis of tumour-infiltrating immune subpopulations in patient tumours.
